Pakistan: Triple therapy combining metformin, SGLT-2 inhibitors, and DPP-4 inhibitors achieves superior glycemic control compared with dual therapy, improving blood glucose control without significant ...
Among patients with type 2 diabetes, the incidence of osteoarthritis and total knee or hip replacement was lower among DPP-4 inhibitor users vs nonusers. The use of dipeptidyl peptidase-4 (DPP-4) ...
aClinical Epidemiology Center, Research and Development Service, VA Saint Louis Health Care System, Saint Louis, MO, USA bDivision of Pharmacoepidemiology, Clinical Epidemiology Center, VA Saint Louis ...
In the ultra-competitive and crowded market for polymer-frame, striker-fired 9 mm handguns, manufacturers seek to balance out their flagship model with an entry-level choice at an affordable price.
Images, and the devices that capture them, are my focus. I've covered cameras at PCMag for the past 14 years, which has given me a front row seat for the changeover from DSLRs to mirrorless cameras, ...
Compared with DPP-4 inhibitor therapy, sustained GLP-1 receptor agonist (GLP-1 RA) therapy was associated with greater short‑ and long‑term improvements in A1c levels and a modest reduction in the ...
‘The Mummy 4’ Directors Say ‘Tomb of the Dragon Emperor’ Is Not Canon: “Rachel Weisz Is In This One”
After nearly 20 years, the third installment in The Mummy franchise is going back in the sarcophagus. Radio Silence directors Matt Bettinelli-Olpin and Tyler Gillett, who have signed on to direct The ...
A cinematic obsessive with the filmic palate of a starving raccoon, Rob London will watch pretty much anything once. With a mind like a steel trap, he's an endless fount of movie and TV trivia, borne ...
In patients with type 2 diabetes (T2D), the risk of hospitalization for heart failure (HHF) was significantly lower with GLP-1RAs than DPP-4 inhibitors while it was similar compared with SGLT-2 ...
Novel treatments are needed for the primary and secondary prevention of heart failure in patients with type 2 diabetes, including individuals with and those without a history of heart failure.
SGLT2 inhibitors showed significantly improved mortality benefits compared with DPP-4 inhibitors in patients with diabetic kidney disease (DKD) in a large target trial emulation study that adds ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results